Bioelectronome. Integrated approach to receptor chemistry, radicals, electrochemistry, cell signaling, and physiological effects based on electron transfer

Journal of Receptors and Signal Transduction

Volumn 27, Issue 4, 2007, Pages 261-294

  Kovacic, Peter ^a   Pozos, Robert S ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Bioelectrochemistry; Bioelectronome; Cell signaling; Electron transfer; Mechanism; Radicals; Receptor

Indexed keywords

AROMATIC NITRO COMPOUND; CATECHOLAMINE; CATECHOLAMINE RECEPTOR; CELL NUCLEUS RECEPTOR; CHOLINERGIC RECEPTOR; DIOXIN; ESTROGEN; ETOPOSIDE; GLUTAMATE RECEPTOR; IMINE; METAL COMPLEX; MITOMYCIN; PHOSPHATE; POLYCHLORINATED BIPHENYL; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RECEPTOR; RYANODINE RECEPTOR;

CELL ACTIVITY; ELECTROCHEMISTRY; ELECTRON TRANSPORT; ELECTROPHYSIOLOGY; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

ACETYLCHOLINE; ANIMALS; CATECHOLAMINES; CELL NUCLEUS; ELECTROCHEMISTRY; ELECTRONS; ESTROGENS; FREE RADICALS; HUMANS; LIGANDS; MUSCLE, SKELETAL; RECEPTORS, CHOLINERGIC; RECEPTORS, GLUTAMATE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SIGNAL TRANSDUCTION;

EID: 34548815034     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890701509133     Document Type: Review

References (147)

1. Kovacic P, Becvar LE. Mode of action of anti-infective agents: Emphasis on oxidative stress and electron transfer. Curr Pharm Des 2000, 6, 143-167.
2. Kovacic P, Osuna JA. Mechanisms of anticancer agents: Emphasis on oxidative stress and electron transfer. Curr Pharm Des 2000, 6, 277-309.
3. Kovacic P, Jacintho JD. Mechanisms of carcinogenesis: Focus on oxidative stress and electron transfer. Curr Med Chem 2001a, 8, 773-796.
4. Kovacic P, Jacintho JD. Reproductive toxins: Pervasive theme of oxidative stress and electron transfer. Curr Med Chem 2001b, 8, 863-892.
5. Kovacic P, Sacman A, Wu-Weis M. Nephrotoxins: Widespread role of oxidative stress and electron transfer. Curr Med Chem 2002, 9, 823-847.
6. Poli G, Cheeseman GH, Dianzani MU, Slater TF. Free radicals in the pathogenesis of liver injury. Pergamon 1989, 1-330.
7. Kovacic P, Thurn LA. Cardiovascular toxins from the perspective of oxidative stress and electron transfer. Curr Vasc Pharmacol 2005, 3, 107-117.
8. Kovacic P, Somanathan R. Neurotoxicity: The broad framework of electron transfer, oxidative stress and protection by antioxidants. Curr Med Chem-CNS Agents 2005, 5, 249-258.
9. Kovacic P, Pozos RS, Somanathan R, Shangari N, O'Brien PG. Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships. Curr Med Chem 2005, 5, 2601-2623.
10. Kovacic P, Cooksy AL. Unfying mechanism for toxicity and addiction by abused drugs: Electron transfer and reactive oxygen species. Med Hypotheses 2005, 64, 367-366.
11. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford University Press 1999, 1-936.
12. Cook DL, Patton HD, Fuchs AF, Hille B, Scher AM, Steiner R. The cellular biology of the endocrine system: An overview, in cellular mechanisms in endocrinology. TextBook Physiol 1989, 2, 152.
13. Osborne K, Zhao H, Fuqua SAW. Selective estrogen receptor modulators: structure, function and clinical use. J Clin Oncol 2000, 18, 3172-3186.
14. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel estrogen receptor expressed in rate prostate and ovary. Proc Natl Acad Sci USA 1996, 93, 5925-5930.
15. Mosselman S, Polman J, Kijkema R. Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996, 392, 49-53.
16. Shiau A, Barstad D, Loria P, et al. The structural basis of estrogen receptor/ coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95, 927-937.
17. Brzozowski AM, Pike AC, Dauter A, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Caelquist M. Molecular basis of agonisms and antagonism in the oestrogen receptor. Nature 1997, 389, 753-758.
18. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 1996, 10, 1167-1177.
19. Maruyama T, Yoshifumi S, Furuke K, Kitoaka Y, Kanzaki H, Yoshimura Y, Yodoi J. Induction of thirorecosin, a redox-active protein, by ovarian steroid hormones during growth and differentiation of endometrial stromal cells in vitro. Endocrinology 1999, 140, 365-372.
20. Wong A, Hwang SM, Cheng HY, Crooke ST. Structure-activity relationships of Badrenergic receptor coupled adenylate cyclase: Implactions of a redox mechanism for the action of agonists at the B-adrenergic receptors. Mol Pharmacol 1987, 31, 368-376.
21. Sanchez RM, Wang C, Gardner G, Orlando L, Tauck DL, Rosenberg PA, Aizenman E, Jensen FE. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J Neurosci 2000, 20, 2409-2417.
22. Lukas RJ, Bennett EL. Chemical modification and reactivity of sulfhydryls and disulfides of rat brain nicotinic-like acetylcholine receptors. J Biol Chem 1980, 255, 5573-5577.
23. Xia, Ruohong, Stangler T, Abramson JJ. Skeletal muscle ryanodine receptor is a redox sensor with a well defined redox potential that is sensitive to channel modulators. J Biol Chem 2000, 275, 36556-36561.
24. Kenakin T. A Pharmacology Primer. Boston, Elsevier, 2004, 2-5.
25. Gringauz A. Introduction to Medicinal Chemistry. New York, Wiley-VCH, 1997, 34.
26. Kovacic P. Protein electron transfer (mechanism and reproductive toxicity): iminium, hydrogen bonding, homoconjugation, amino acid side chains and cell signaling. Birth Defects Res Part C 2007, 81, 51-64.
27. DeYulia GJ Jr, Carcamo JM, Borquez-Ojeda O, Shelton CC, Golde DW. Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilities cell signaling. Proc Natl Acad Sci USA 2005, 102, 5044-5049.
28. DeYulia GJ, Carcamo JM. EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem Biophys Res Commun 2005, 334, 38-42.
29. Wedgwood S, Black SM. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 2005, 288, L480-L487.
30. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006, 290, R96-R104.
31. Lim Sy, Tennant GM, Kennedy S, Wainwright CL, Kane KA. Activation of mouse protease-activated receptor-2 induces lymphocyte adhesion and generation of reactive oxygen species. Br J Pharmacol 2006, 149, 591-599.
32. Hao Q, Rutherford SA, Low B, Tang H. Selective regulation of hydrogen peroxide signaling by receptor tyrosine phosphatase-alpha. Free Radic Biol Med 2006, 41, 302-10.
33. Lund AK, Peterson SL, Timmins GS, Walker MK. Endothelin-1-mediated increase in reactive oxygen species and NADPH Oxidase activity in hearts of aryl hydrocarbon receptor (AhR) null mice. Toxicol Sci 2005, 88, 265-273.
34. Zhou Q, Mend D, Yan B, Jiang BH, Fang J. Transactivation of epidermal growth factor receptor by insulin-like growth factor 1 requires basal hydrogen peroxide. FEBS Lett 2006, 580, 5161-5166.
35. Asghar M, Banday AA, Fardoun RZ, Lokhandwala MF. Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2. Free Radic Biol Med 2006, 40, 13-20.
36. Schmitt TL, Klein H, Droge W. Hydrogen peroxide inhibits activity of the IGF-1 receptor kinase. Redox Rep 2006, 11, 105-109.
37. Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 2005, 280, 17497-17506.
38. von Montfort C, Fernau NS, Beier JI, Sies H, Klotz LO. Extracellular generation of hydrogen peroxide is responsible for activation of EGF receptor by ultraviolet A radiation. Free Radic Bio Med 2006, 41, 1478-1487.
39. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, Chen CF, Lian WS, Meng TC, Chiu WT, Chen JJ. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 2006, 69, 1347-1355.
40. Wang X, Tong M, Chinta S, Raj Ju, Gao Y. Hypoxia-induced reactive oxygen species downregulate ETB receptor-mediated contraction of rat pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2006, 290, L570-580.
41. Iiyama M, Kakihana K, Kurosu T, Miura O. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal 2006, 18, 174-182.
42. Lejeune D, Hasanuzzaman M, Pitcock A, Francis J, Sehgal I. The superoxide scavenger TEMPOL-induces urokinase receptor (uPAR) expression in human prostate cancer cells. Mol Cancer 2006, 5, 21.
43. Bonello MR, Bobryshev YV, Khachigian LM. Peroxide-inducible Ets-1 mediates platelet-derived growth factor receptor-alpha gene transcription in vascular smooth muscle cells. Am J Pathol 2005, 167, 1149-1159.
44. Harfouche R, Malak NA, Brandes RP, Karsan A, Irani K, Hussain SN. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 2005, 19, 1728-1730.
45. Qin L, Li G, Qian X, Liu Y, Wu X, Liu B, Hong JS, Block ML. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 2005, 52, 78-84.
46. Madesh M, Hawkins BJ, Milovanova T, Bhanumathy CD, Joseph SK, Ramachandrarao SP, Sharma K, Kurosaki T, Fisher AB. Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis. J Cell Biol 2005, 170, 1079-1090.
47. Pines A, Perrone L, Bivi N, Romallo M, Damante G, Gulisano M, Kelley MR, Quadrifoglio F, Tell G. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 2005, 33, 4379-4394.
48. Sureda A, Hebling U, Pons A, Mueller S. Extracellular H2O2 and not superoxide determines the compartment-specific activation of transferrin receptor by iron regulatory protein 1. Free Radic Res 2005, 39, 817-824.
49. Mukherjee TK, Mukhopadhyay S, Hoidal JR. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 2005, 1744, 213-223.
50. Kim MH, Cho HS, Jung M, Hong MH, Lee SK, Shin BA, Ahn BW, Jung YD. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int J Oncol 2005, 26, 1669-1674.
51. Garrett RH, Grisham CM. Biochemistry. Belmont, CA, Thomson Brooks/Cole, 1999, S-50.
52. Kovacic P, Wakelin LPS. DNA molecular electrostatic potential: novel perspective for the mechanism of action of anticancer drugs involving electron transfer and oxidative stress. Anti-Canc Drug Des 2001, 16, 1-10.
53. Kovacic P, Pozos RS. Cell signaling (mechanism and reproductive toxicity): Redox chains, radicals, electrons, relays, conduit, electrochemistry and other medical implications. Birth Defects Res Part C 2006, 78, 333-344.
54. Sheriar GH, Mikhail AF, Georgia M, Hannah Monyer, Roberto B. Electrical synapses: A dynamic signaling system that shapes the activity of neuronal networks. Biochim Biophys Acta 2004, 1662, 113-137.
55. Hancock GT. Cell Signaling. New York, Oxford University Press, 2005, 1-296.
56. Forman HG, Cadenas E, Eds. Oxidative Stress and Signal Transduction, New York, Chapman and Hall, 1997, 1-475.
57. Demple B. Oxidative stress and signal transduction. In: Handbook of Cell Singaling 2004, 78, 293-307.
58. Hansen JM. Oxidative stress as a mechanism of teratogenesis. Birth Defects Res Part C 2006, 78, 293-307.
59. Jones DP. Redifining oxidative stress. Antioxid Redox Signal 2006, 8, 1865-1879.
60. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106, 852-859.
61. Miller AA, Drummond GR, Sobey CG. Reactive oxygen species in the cerebral circulation: Are they all bad? Antioxid Redox Signal 2006, 8, 1113-1120.
62. Bunik VI, Scchloss JV, Pinto JT, Gibson GE, Cooper AJ. Enzyme-catalyzed side reactions with molecular oxygen may contribute to cell signaling and neurodegenerative diseases. Neurochem Res 2007, 32, 871-891.
63. Ling-Zhi Liu, Xiao-Wen Hu, Chang Xia, Jie He, Qiong Zhou, Xianglin Shi, Jing Fang, Bing Hua Jiang. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 2006, 41, 1521-1533.
64. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: 'It ain't over 'til it's over.' Trends Cell Biol 2000, 10, 147-154.
65. Kovacic P. Unifying mechanism for bacterial cell signalers (4,5-dihydroxy-2,3-pentanedione, lactones and oligopeptides): Electron transfer and reactive oxygen species. Practical medical features. Med Hypotheses 2007, in press.
66. Kaufmann GF, Sartorio R, Lee S-H, Rogers CJ, Meijler MM, Moss JA, Chapmam B, Brogan AP, Dickerson TJ, Janda KD. Revisiting quorum sensing: Discovery of additional chemical and biological functions for 3-oxo-n-acylhomoserine lactones. PNAS 2005, 102, 309-314.
67. Diggle SP, Matthijs S, Wright VJ, Fletcher MP, Chhabra SR, Lamont IL, Kong X, Hider RC, Cornelis P, Camara M, Williams P. The pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol 2007, 14, 87-96.
68. Bredenbruch F, Geffers R, Mimtz M, Buer J, Haussler S. The Pseudomonas aerugenosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol 2006, doi:10.1111/j.1462-2920.2006.0125.x.
69. Takada T, Barton JK. DNA charge transport leading to disulfide bond formation. J Am Chem Soc 2005, 127,12204-12205.
70. Wan J, Bedham HJ, Winn L. The role of c-MYB in benezene-initiated toxicity. Chem Biol Interact 2005, 153-154, 171-178.
71. Ruiz-Ramos R, Cebrian ME, Garrido E. Benzoquinone activated the ERK/MAPK signaling pathway via ROS production in HL-60 cells. Toxicology 2005, 209, 279-287.
72. Hanzlik RP, Harriman SP, Frauenhoff MM. Covalent binding of benzoquinone to reduced ribonuclease. Adduct structures and stoichiometry. Chem Res Toxicol 1994, 7, 177-184.
73. Peng D, Qian C, Sun Y, Barajas MA, Prieto J. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol 2000, 32, 975-985.
74. Moseieniak G, Sliwinska, M, Piwocka k, Sikora E. Curcumin abolishes apoptosis resistance of calcitriol-differentiated HL-60 cells. FEBS Lett 2006, 580, 4653-4660.
75. Lin J, Hutchinson L, Gaston SM, Raab G, Freeman MR. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation. J Biol Chem 2001, 276, 301727-30132.
76. Albihn A, Loven J, Ohlsson J, Osorio LM, Henriksson M. cMyc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling. J Cell Biochem 2006, 98, 1597-1614.
77. Sawada M, Nakashima S, Banno Y, Yamakawa H, Hayashi K, Takenaka K, Nishimura Y, Sakai N, Nozawa Y. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells. Cell Death Differ 2000, 7, 761-772.
78. Brantley-Finley C, Lyle CS, DU L, Goodwin ME, Hall T, Szwedo D, Kaushal GP, Chambers TC. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol 2003, 66, 459-469.
79. Ferraro C, Quemenueur L, Fournel S, Prigent AF, REvillard JP, Bonnefoy-Berard N. The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ 2000, 7, 197-206.
80. Sebestyén A, Mihalik R, Peták I, Kopper L. Modulation of apoptosis signaling in etoposide-treated lymphoma cells. Anticancer Res 1997, 17, 2609-2614.
81. Yao KS, O'Dwyer PJ. Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem Pharmacol 1995, 49, 275-282.
82. Kang YH, Lee KA, Ryu CJ, Lee HG, Lim JS, Park SN, Paik SG, Yoon DY. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells. Cancer Lett 2006, 237, 33-44.
83. Ise K, Sato Y, Matsuyama S, Gunji T, Ishii S, Yamashita M, Kanazawa Y, Gotoh M. Transforming growth factor-beta signaling is enhanced following mitomycin-C treatment of islet xenograft. Transplant Proc 2004, 36, 1183-1185.
84. Miura Y, Kataoka H, Joh T, Tada T, Asai K, Nakanishi M, Okada N, Okada H. Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 9Waf1/Cip1) promoter. Microbiol Immunol 2004, 48, 137-145.
85. Pirnia F, Schneider E, Betticher DC, Borner MM. Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ 2002, 9, 905-914.
86. Crowston JG, Chang LH, Constable PH, Daniels JT, Akbar AN, Khaw PT. Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts. Invest Ophthalmol Vis Sci 2002, 43, 692-699.
87. Keller KL, Overbeck-Carrick TL, Beck DJ. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and REcFOR pathways of homologous recombination. Mutat Res 2001, 486, 21-29.
88. Sun HZ, Wu SF, Tu ZH. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity. Cell Res 2001, 11, 107-115.
89. Hiwasa T, Chen Z, Nomura J, Yamamori H, Tashiro T, Nakajima N, Suzuki N. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1. Anticancer Res 1999, 19, 3915-3920.
90. Costa LG. Signal transduction in environmental neurotoxicity. Annu Rev Pharmacol Toxicol 1998, 38, 21-43.
91. Chen G, Bunce NJ. Interaction between halogenated aromatic compounds in the Ah receptor signal transduction pathway. Environ Toxicol 2004, 19, 480-409.
92. Shimokawa N, Miyazaki W, Iwasaki T, Koibuchi N. Low dose hydroxylated PCB induces c-jun expression in PC12 cells. Neurotoxicology 2006, 27, 176-183.
93. Fonnum F, Mariussen E, Reistad T. Molecular mechanisms involved in the toxic effects of polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs). J Toxicol Environ Health A 2006, 69, 21-35.
94. Basha MR, Braddy NS, Zawia NH, Kodavanti PR. Ontogenetic alterations in prototypical transcription factors in the rat cerebellum and hippocampus following perinatal exposure to a commercial PCB mixture. Neurotoxicology 2006, 27, 118-124.
95. Kodavanti PR, Ward TR. Differential effects of commercial polybrominated diphenyl ether and polychlorinated biphenyl mixtures on intracellular signaling in rat brain in vitro. Toxicol Sci 2005, 85, 952-962.
96. Machala M, Bláha L, Vondrácek J, Trosko JE, Scott J, Upham BL. Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: inhibitory potencies and screening for potential mode(s) of action. Toxicol Sci 2003, 76(1), 102-111.
97. Canzoniero LM, Adornetto A, Secondo A, Magi S, Dell'aversano C, SCorziello A, Amoroso S, Di Renzo G. Involvement of the nitric oxide/protein kinase G pathway in polychlorinated biphenyl-induced cell death in SH-SY 5Y neuroblastoma cells. J Neurosci Res 2006, 84, 692-697.
98. Eum SY, Rha GB, Hennig B, Toborek M. C-Src is the primary signaling mediator of polychlorinated biphenyl-induced interleukin-8 expression in a human microvascular endothelial cell line. Toxicol Sci 2006, 92, 311-320.
99. Ma R, Sassoon DA. PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect 2006, 114, 898-904.
100. Smithwick LA, Smith A, Quensen JF III, Stack A, London L, Morris PJ. Inhibition of LPS-induced splenocyte proliferation by ortho-substituted polychlorinated biphenyl congeners. Toxicology 2003, 188, 319-333.
101. Kovacic P, Somanathan R. Mechanism of teratogenesis: electron transfer, reactive oxygen species, and antioxidants. Birth Defects Res Part C 2006, 78, 308-325.
102. Safe S, Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor α cross-talk and mechanisms of action. Chem Res Toxicol 2003, 16, 807-812.
103. Wang L, Hingerty BE, Shapiro R, Broyde S. Structural and stereoisomer effects of model estrogen quinone-derived DNA adducts: N6-(2-hydroxyestron- 6(alpha,beta)-yl)-2′-deoxyadenosine and N2-(2-hydroxyestron-6(alpha,beta)- yl)-2′deoxyguanosine. Chem Res Toxicol 2004, 17, 311-324.
104. Markushin Y, Zhong W, Cavalieri EL, Rogan EG, Small GJ, Yeung ES, Jankowiak R. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem Res Toxicol 2003, 16, 1107-1117.
105. Lin PH, Nakamura J, Yamaguchi S, Asakura S, Swenberg JA. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis 2003, 24, 1133-1141.
106. Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adduct: dissection of the reaction of 3,4-estrone quinone and its radical anion and radical cation with deoxynucleosides and DNA. Chem Res Toxicol 1999, 12, 1247-1253.
107. Jankowiak R, Zamzow D, Stack DE, Todorovic R, Cavalieri EL, Small GJ. Spectral characterization of fluorescently labeled catechol estrogen 3,4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue. Chem Res Toxicol 1998, 11, 1339-1345.
108. Terashima I, Suzuki N, Dasaradhi L, Tan CK, Downey KM, Shibutani S. Translesional synthesis on DNA templates containing an estrogen quinone-derived adduct: N2-(2-hydroxyestron-6-yl)-2′-deoxyguanosine and N6-(2-hydroxyestron-6-yl)-2′deoxyadenosine. Biochemistry 1998, 37, 13807-13815.
109. Roy D, Abul-Hajj YJ. Estrogen-nucleic acid adducts: guanine is major site for interaction between 3,4-estrone quinone and COIII gene. Carcinogenesis 1997, 18, 1247-1249.
110. Terashima I, Suzuki N, Shibutani S. Mutagenic properties of estrogen quinone-derived DNA adducts in simian kidney cells. Biochemistry 2001, 40, 166-172.
111. Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 1996, 54, 287-293.
112. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307, 1625-1630.
113. Nakazawa T, Takahashi H, Shimura M. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Res 2006, 1093(1), 141-149.
114. Márquez DC, Chen HW, Curran EM, Welshons, WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 2006, 246, 91-100.
115. Hisamoto K, Bender JR. Vascular cell signaling by membrane estrogen receptors. Steroids 2005, 70, 382-387.
116. Goodenough S, Schäfer M, Behl C. Estrogen-induced cell signaling in a cellular model of Alzheimer's disease. J Steroid Biochem Mol Biol 2003, 84, 301-305.
117. Fatehi M, Kombian SB, Saleh TM. 17beta-estradiol inhibits outward potassium currents recorded in rat parabranchial nucleus cells in vitro. Neuroscience 2005, 135, 1075-1086.
118. Canesi L, Ciacci C, Betti M, Lorusso LC, Marchi B, Burattini S, Falcieri E, Gallo G. Rapid effects of 17beta-estradiol on cell signaling and function of mytilus hemocytes. Gen Comp Endocrinol 2004, 136, 58-71.
119. Lieberherr M, Grosse B, Kachkache M, Balsan S. Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 1993, 8, 1365-1376.
120. Jacintho J, Kovacic P. Neurotranemission and neurontoxicity by nitric oxide, catecholamines and glutamate: unifying themes of reactive oxygen species and electron transfer. Curr Med Chem 2003, 10, 2693-2704.
121. Zhao L, Ching L, Kestell P, Kelland LR, Baguley BC. Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability. Int J Cancer 2005, 116, 322-326.
122. Zhou S, Kestell P, Baguley BC, Paxton JW. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA): A new biological response modifier for cancer therapy. Investig New Drugs 2002, 20, 281-295.
123. Baguley BC. Small-molecule cytokine inducers causing tumor necrosis. Curr Opin Investig Drugs 2001, 2, 267-975.
124. Kovacic P. Fundamental, electron transfer mechanism by pyrylium-type ions for the anticancer drugs 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA). Curr Med Chem-Anticancer Agents 2005, 5, 501-506.
125. Rabinovitz M. The structure of flavone-8-acetic acid, a chemotherapeutic agent and its application in drug design. J Enzyme Inhibit 1988, 2, 151-152.
126. Moon K, Kaifer AE. Modes of binding interaction between viologen guests and the cucurbit[7]uril host. Org Lett 2004, 6, 185-188.
127. Bowles MR, Mulhern TD, Gordon RB, Inglis HR, Sharpe IA, Cogill JL, Pond SM. Bound Tris confounds the identification of binding site residues in a paraquat single chain. J Biochem (Tokyo) 1997, 122, 101-108.
128. Bowles MR, Pond SM. The importance of electrostatic interactions in the binding of paraquat to its elicited monoclonal antibody. Mol Immunol 1990 27, 847-852.
129. Hogg PJ, Johnston SC, Bowles MR, Ponds SM, Winzor DJ. Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: The binding of paraquat to its elicited mouse monoclonal antibody. Mol Immunol 1987, 24, 797-801.
130. Sullivan TM, Montgomery MR. The relationship between paraquat accumulation and covalent binding in rat lung slices. Drug Metab Dispos 1983, 11, 526-530.
131. Giri SN, Lunsman P. Binding of [methyl-3h] paraquat to rat, rabbit, hamster, mouse and guinea pig lung proteins, in vitro. Toxicol Lett 1981, 9, 93-100.
132. Minchin RF. Evidence for the reversible binding of paraquat to deoxyribonucleic acid. Chem Biol Interact 1987, 61, 139-149.
133. Baguley BC, Wakelin LPG, Jacintho JD, Kovacic P. Mechanism of action of DNA intercalating acridine-based drugs: How important and contributions from electron transfer and oxidative stress? Curr Med Chem 2003, 10, 2643-2650.
134. Pastwa E, Ciesielska E, Piestrzeniewicz MK, Denny WA, Gniazdowski M, Szmigiero L. Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide (DACA) and its analogues. Biochem Pharmacol 1998, 56, 351-359.
135. Robertson IG, Bland TJ. Inhibition of SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide. Biochem Pharmacol 1993, 45, 2159-2162.
136. Ferguson LR, Turner PM, Baguley BC. Induction of mitotic crossing-over by the topoisomerase II poison DACA (N-[2-dimethylamnio)ethyl]acridine-4- carboxamide) in Saccharomyces cerevisiae. Mutat Res 1993, 289, 157-163.
137. Haldane A, Holdaway KM, Finlay GJ, Baguley BC. Cytokinetic differences in the action of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin. Cancer Chemother Pharmacol 1993, 32, 463-470.
138. Stryer L. Biochemistry. New York, Freeman, 1995, 332-339.
139. Salem L. The sudden polarization effect and its possible role in vision. Acc Chem Res 1979, 12, 87-92.
140. Bonacic-Koutecky V, Koutecky J, Michl J. Neutral and charged biradicals, zwitterions, funnels in Sl, and proton translocation: their role in photochemistry, photophysics, and vision. Angew Chem Int Ed Engl 1987, 26, 170-189.
141. Sheves M, Nakanishi K, Honig B. Through-space electrostatic effects in electronic spectra. Experimental evidence for the external point-charge model of visual pigments. J Am Chem Soc 1979, 101, 7086-7088.
142. Hubbell WL, Altenbach C, Hubbell CM, Khorana HG. Rhodopsin structure, dynamics and activation. In: Advances in Protein Chemistry. Membrane Proteins. Richard FM, Eisenberg DS, Kuriyan J. Eds. New York, Academic Press, 63, 2003 243-290.
143. Schwartz T. Molecular structure and function of TTMG-protein coupled receptors. In: Textbook of Receptor Pharmacology. Foreman JC, Johnsasen T., Eds. New York, CRC Press, 2002, 88.
144. Crawford PW, Kovacic P, Gilman NW, Ryan MD. Charge transfer mechanism for benzodiazepine (BZ) action. Correlation of reduction potential of BZ iminium with structure and drug activity. Bioelectrochem Bioenerg 1986, 16, 407-426.
145. Kovacic P, Ames JR, Tayler EC Ryan MD. Electrochemistry of the anticancer agents methotrexate and α-diflouoromethylornithine in iminium form. J Pharm Sci 1988, 77, 999-1002.
146. Maejima M, Maruoka Y, Sawada T, Ando T, Kobayashi M, Ogiuchi H. Expression of vascular endothelial growth factor (VEGF) and specific receptors (Flt-1 and Flk-1) in rat tongue carcinogenesis induced by 4-nitroquinofine 1-oxide. Acta Histochem Cytochem 2002, 35, 331-341.
147. Li Y, Wang L, Li S, Guo T, Guo X, Yan P, Chen Y, Wang L, Lu C. p53 protein activates the transcription of human proliferating cell nuclear antigen in response to 4-nitroquinoline N-oxide treatment. Int J Biochem Cell Biol 2005, 27, 416-426.